{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:47:21Z","timestamp":1766551641326},"reference-count":35,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.03.097","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T13:51:23Z","timestamp":1428760283000},"page":"4281-4287","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Brazilian meningococcal C conjugate vaccine: Scaling up studies"],"prefix":"10.1016","volume":"33","author":[{"given":"Renata Chagas","family":"Bastos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iaralice Medeiros","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton Neto","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia de Paiva","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elza Scott","family":"Figueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Lurdes","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Jessouroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Godinho da Silva","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo de Andrade","family":"Medronho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivna Alana Freitas Brasileiro","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.03.097_bib0180","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30S","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0185","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.carbpol.2008.09.032","article-title":"Meningococcal polysaccharide vaccines: a review","volume":"75","author":"Joshi","year":"2009","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/016164110X12644252260754","article-title":"Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention","volume":"32","author":"S\u00e1fadi","year":"2010","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.097_bib0195","first-page":"195","article-title":"A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines","volume":"88","author":"S\u00e1fadi","year":"2012","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0200","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jval.2011.05.045","article-title":"Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil","volume":"14","author":"Soarez","year":"2011","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.097_bib0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S0037-86822012000300009","article-title":"Bacterial meningitis and living conditions","volume":"45","author":"Souza","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S0950268812001689","article-title":"The epidemiology of meningococcal disease in Latin America 1945\u20132010: an unpredictable and changing landscape","volume":"141","author":"S\u00e1fadi","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.097_bib0215","first-page":"379","article-title":"Braz Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil","volume":"8","author":"Tauil","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0220","series-title":"Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o\u2014Sinan Net","author":"Minist\u00e9rio da Sa\u00fade\/SVS","year":"2007"},{"issue":"6","key":"10.1016\/j.vaccine.2015.03.097_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0064524","article-title":"Bacterial meningitis in Brazil: baseline epidemiologic assessment of the decade prior to the introduction of pneumococcal and meningococcal vaccines","volume":"8","author":"Azevedo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0230","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1016\/j.vaccine.2007.07.037","article-title":"Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid","volume":"25","author":"Silveira","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0235","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1016\/j.vaccine.2007.06.018","article-title":"Comparison of Neisseria meningitidis serogroupW135 polysaccharide\u2013tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide","volume":"25","author":"Gudlavalleti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0240","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0245","series-title":"Proceedings of the 17th international pathogenic neisseria conference","first-page":"169","article-title":"Phase I study of a meningococcal C strain 2135 conjugate vaccine","author":"Martins","year":"2010"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0250","series-title":"Proceedings of the 18th international pathogenic neisseria conference","first-page":"283","article-title":"Phase II clinical study of a Brazilian meningococcal C conjugate vaccine","author":"Engstrom","year":"2012"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.097_bib0255","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/nm1218","article-title":"The process development challenges for a new vaccine","volume":"11","author":"Buckland","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0260","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1016\/j.vaccine.2007.06.008","article-title":"Scale up for bulk production of vaccine against meningococcal disease","volume":"25","author":"Baart","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0958-2118(00)86634-3","article-title":"Scale up and scale-down of membrane-based separation processes","volume":"117","author":"Ball","year":"2000","journal-title":"Membr Technol"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0270","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.vaccine.2011.10.095","article-title":"Process optimization and scale up for production of rabies vaccine live adenovirus vector (AdRG1.3)","volume":"30","author":"Shen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivative with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0280","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","article-title":"Quantitative estimation of sialic acids","volume":"24","author":"Svennerholm","year":"1957","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0290","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","article-title":"Immunochemistry of groups A, B, and C meningococcal polysaccharide\u2013tetanus toxoid conjugates","volume":"127","author":"Jennings","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0295","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1016\/j.vaccine.2010.05.079","article-title":"Determination of hydrazine in a meningococcal C conjugate vaccine intermediary product","volume":"28","author":"Bastos","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0300","series-title":"Statistical inference","author":"Casella","year":"2002"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0305","series-title":"WHO technical report series, no. 924","article-title":"Annex 2 recommendations for the production and control of meningococcal group C conjugate vaccines","author":"WHO","year":"2004"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0008-6215(96)00253-4","article-title":"Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production","volume":"296","author":"Lemercinier","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0315","series-title":"NMR spectroscopy in pharmaceutical analysis","first-page":"341","article-title":"NMR assays for carbohydrate-based vaccines","author":"Jones","year":"2008"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0320","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/elps.201300298","article-title":"Single validation of CE method for determining free polysaccharide content in a Brazilian meningococcal C conjugate vaccine","volume":"34","author":"Souza","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0325","series-title":"Process scale bioseparations for the biopharmaceutical industry","first-page":"523","article-title":"Linear scale up of ultrafiltration of high viscosity process streams","author":"Daniels","year":"2007"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0330","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/(SICI)1097-0290(19970905)55:5<737::AID-BIT4>3.0.CO;2-C","article-title":"Linear scale ultrafiltration","volume":"55","author":"Van Reis","year":"1997","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0335","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2011.11.108","article-title":"Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi","volume":"30","author":"Micoli","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0340","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1016\/j.vaccine.2007.06.018","article-title":"Comparison of Neisseria meningitidis serogroup W135 polysaccharide\u2013tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide","volume":"25","author":"Gudlavalleti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0345","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","article-title":"Preparation of bacterial polysaccharide\u2013protein conjugates: analytical and manufacturing challenges","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.097_bib0350","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2011.05.081","article-title":"A comparative study to evaluate the safety and immunogenicity of two lots of Haemophilus influenzae type-B conjugate vaccine manufactured at different scales","volume":"29","author":"Hirve","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:21:25Z","timestamp":1691580085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15004272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":35,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15004272"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brazilian meningococcal C conjugate vaccine: Scaling up studies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}